ORPHAN Cures Act
12/15/2023, 4:09 PMSummary of Bill S 3131
Bill 118 s 3131, also known as the ORPHAN Cures Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to provide support and resources for the development of treatments and cures for rare diseases, also known as orphan diseases.The ORPHAN Cures Act aims to address the challenges faced by patients with rare diseases, who often struggle to find effective treatments due to the limited research and development in this area. The bill proposes to increase funding for research on rare diseases, as well as provide incentives for pharmaceutical companies to develop treatments for these conditions.
Additionally, the ORPHAN Cures Act includes provisions to improve access to orphan drugs for patients, streamline the approval process for these treatments, and enhance collaboration between researchers, healthcare providers, and patient advocacy groups. Overall, the ORPHAN Cures Act seeks to accelerate the development of treatments and cures for rare diseases, ultimately improving the quality of life for patients affected by these conditions. It is currently under review in Congress, and its passage could have a significant impact on the rare disease community in the United States.
Read the Full Bill
Current Status of Bill S 3131
Bill S 3131 is currently in the status of Bill Introduced since October 25, 2023. Bill S 3131 was introduced during Congress 118 and was introduced to the Senate on October 25, 2023. Bill S 3131's most recent activity was Read twice and referred to the Committee on Finance. as of October 25, 2023Bipartisan Support of Bill S 3131
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
2Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 3131
Primary Policy Focus
HealthAlternate Title(s) of Bill S 3131
ORPHAN Cures ActORPHAN Cures ActOptimizing Research Progress Hope And New Cures ActA bill to amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.Comments
Most relevant
Sponsors and Cosponsors of S 3131
Latest Bills
NTIA Reauthorization Act of 2025
Bill HR 2482April 1, 2025
Providing for congressional disapproval of the proposed foreign military sale to Israel of certain defense articles and services.
Bill HJRES 83April 1, 2025
Expressing support for the designation of the week of April 6 through April 12, 2025, as "National Water Week".
Bill HRES 274April 1, 2025
Reaffirming the commitment of the Federal Government to historically Black colleges and universities and honoring their enduring legacy and contributions.
Bill HRES 269April 1, 2025
Expressing support for the diplomatic relations required to encourage the Government of Mexico to fulfill its water deliveries on an annual basis to the United States under the treaty between the United States and Mexico regarding the utilization of the Colorado and Tijuana Rivers and of the Rio Grande.
Bill HRES 273April 1, 2025
Providing for congressional disapproval of the proposed foreign military sale to Israel of certain defense articles and services.
Bill HJRES 85April 1, 2025
Raising awareness of the racial disparities in the impact of colorectal cancer on the Hispanic community.
Bill HRES 276April 1, 2025
Providing for congressional disapproval of the report of enhancement or upgrade of sensitive foreign military related to a sale to the Government of Israel of certain defense articles and services.
Bill HJRES 86April 1, 2025
Supporting the goals and ideals of International Transgender Day of Visibility.
Bill HCONRES 23April 1, 2025
Providing for congressional disapproval of the proposed foreign military sale to Israel of certain defense articles and services.
Bill HJRES 84April 1, 2025
ORPHAN Cures Act
Bill HR 5539December 19, 2024